Hims & Hers Health, Inc. (HIMS) CEO Andrew Dudum On Q4 2021 Results - Earnings Call Transcript

SA Transcripts
154.12K Followers

Q4: 2022-02-22 Earnings Summary

EPS of -$0.15 misses by $0.05
 | Revenue of $84.70M (104.26% Y/Y) beats by $7.91M

Hims & Hers Health, Inc. (NYSE:HIMS) Q4 2021 Earnings Conference Call February 22, 2022 5:00 PM ET

Company Participants

Jay Spitzer - Senior VP & Investor Relations
Andrew Dudum - Chief Executive Officer
Yemi Okupe - Chief Financial Officer

Conference Call Participants

Michael Cherny - Bank of America
Matthew Shea - Piper Sandler
Adam Heussner - Credit Suisse
Daniel Grosslight - Citi
Ivan Feinseth - Tigress Financial Partners

Disclaimer*: This transcript is designed to be used alongside the freely available audio recording on this page. Timestamps within the transcript are designed to help you navigate the audio should the corresponding text be unclear. The machine-assisted output provided is partly edited and is designed as a guide.

Operator

0:02 Good afternoon. My name is Emma, and I will be your conference operator today. At this time, I’d like to welcome everyone to the Hims & Hers Health Fourth Quarter 2021 Earnings Results Conference Call. All lines have been placed on mute to prevent any background noise. After the speakers remarks, there will be a question-and-answer session. [Operator Instructions] Thank you.

0:33 Jay Spitzer Senior Vice President and Investor Relations, you may begin your conference.

Jay Spitzer

0:40 Good afternoon ladies and gentlemen. Welcome to the Hims & Hers Health fourth quarter and fiscal year 2021 earnings call. On the call with me today is, Andrew Dudam, Co-Founder and our Chief Executive Officer; as well as Yemi Okupe, our Chief Financial Officer. Beforehand you over to Andrew I was usual take you through the legal and safe harbor and cautionary declarations.

1:03 Certain statements and projections of future results made in this presentation constitutes forward-looking statements that are based on our current market competitive and regulatory expectations and are subject to risks uncertainties that could cause actual results to vary materially. We undertake

Recommended For You

About HIMS Stock

SymbolLast Price% Chg
Market Cap
PE
Yield
Rev Growth (YoY)
Short Interest
Prev. Close
Compare to Peers

More on HIMS